+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 4 Actively Recruiting clinical trials

M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are evaluating the accuracy and precision of blood pressure and pulse rate measurements generated by the Aktiia Periodic Optical Blood Pressure Monitoring Device Aktiia.product-G1-US worn on the wrist. This study includes a minimum of 85 participants representative of the US population, aged 22 to 59 years, to assess device performance over a period of up to 7 days after initial use. The study is interventional and sponsored by Aktiia SA. Participants will have their blood pressure and pulse rate measured at multiple timepoints using the Aktiia device and reference methods, including double auscultation with a cuff for blood pressure and an electrocardiogram for pulse rate. The study spans 3 visits across 7 days, focusing on evaluating the devices measurement accuracy compared to these references. During the study, participants will attend several visits where blood pressure and pulse rate readings will be taken, and adherence to study procedures will be monitored. Researchers will analyze differences in blood pressure averages and variability over 7 days, as well as heart rate measurement errors. The total study duration is one week, with safety and performance data collected throughout this period.

Age: 22Years - 59YearsAll GendersPhase Not Applicable
1 location
S

Actively Recruiting

Researchers are evaluating two platelet-based treatments spaced four weeks apart compared to sham procedures for treating painful lumbar degenerative disc disease. This single-blind, randomized, placebo-controlled study aims to observe improvements in patient-reported outcomes from baseline to three months after the second treatment, with ongoing assessment of effectiveness and durability up to twelve months. The study includes adults aged 25 to 65 years with confirmed degenerative disc disease who have not responded to prior conservative treatments. Participants receive either two treatments involving platelet-rich plasma, platelet lysate, and platelet poor plasma injections into specific areas of the lumbar spine or two sham procedures mimicking the treatment without injecting any substances. The treatments involve drawing and processing the patients blood, followed by ultrasound or x-ray guided injections into the multifidus muscle, epidural space, facet joints, tendon insertions, and ligaments at the affected spinal levels. The sham group undergoes needle placements without injections. After three months, patients in the sham group may crossover to receive the real treatment and continue follow-up accordingly. Participants attend a pretreatment visit at or before enrollment, with follow-up visits at three and twelve months post-injection. They complete questionnaires assessing pain and function at one, three, six, and twelve months. Researchers measure outcomes including pain scales, functional indexes, disability scores, medication use, adverse events, and additional treatments. The total participation lasts up to one year with ongoing monitoring of clinical outcomes and safety throughout the study period.

Age: 25Years - 65YearsAll GendersPhase Not Applicable
2 locations
E

Actively Recruiting

Researchers are evaluating a new approach to treat injuries of the alar, accessory, and transverse ligaments in patients with craniocervical junction CCJ instability. This study aims to assess the safety and effectiveness of using an anterior approach through the posterior oropharynx combined with bone marrow concentrate therapy. The trial is a single-center, randomized, controlled study that compares two bone marrow concentrate treatments to two sham procedures in patients suffering from symptoms related to CCJ instability, including headaches and dizziness. Participants in the treatment group will undergo bone marrow aspiration from the posterior iliac crest to prepare platelet rich plasma and platelet lysate mixed with bone marrow cells. Under anesthesia, this mixture will be injected into the injured ligaments using fluoroscopy and endoscopic guidance through the posterior oropharynx. Patients will also receive injections to upper cervical ligaments and facets. The control group will receive similar bone marrow aspiration but will undergo sham injections designed to mimic the procedure without the active treatment. Both groups will receive two procedures spaced three months apart. Throughout the study, patients will be assessed using clinical outcome questionnaires and digital motion X-rays at three months following the second procedure. Outcomes include changes in headache impact, neck disability, pain levels, and physical function. Safety will also be monitored through adverse event tracking for six months after treatment. Control participants may opt to receive the active treatment after the initial evaluation period. The total study duration extends up to 2030, with ongoing monitoring and evaluation.

Age: 18Years - 65YearsAll GendersPhase Not Applicable
1 location